Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217,629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia.
Hu Y, Wu Z, Luo Y, Shi J, Yu J, Pu C, Liang Z, Wei G, Cui Q, Sun J, Jiang J, Xie J, Tan Y, Ni W, Tu J, Wang J, Jin A, Zhang H, Cai Z, Xiao L, Huang H. Hu Y, et al. Among authors: wang j. Clin Cancer Res. 2017 Jul 1;23(13):3297-3306. doi: 10.1158/1078-0432.CCR-16-1799. Epub 2016 Dec 30. Clin Cancer Res. 2017. PMID: 28039267 Clinical Trial.
Generating hESCs with reduced immunogenicity by disrupting TAP1 or TAPBP.
Cui D, Wang J, Zeng Y, Rao L, Chen H, Li W, Li Y, Li H, Cui C, Xiao L. Cui D, et al. Among authors: wang j. Biosci Biotechnol Biochem. 2016 Aug;80(8):1484-91. doi: 10.1080/09168451.2016.1165601. Epub 2016 Apr 12. Biosci Biotechnol Biochem. 2016. PMID: 27068360
217,629 results
You have reached the last available page of results. Please see the User Guide for more information.